incb050465
Showing 1 - 4 of 4
Colorectal Cancer (CRC), Endometrial Cancer, Melanoma Trial in United States (Pembrolizumab, itacitinib, INCB050465)
Completed
- Colorectal Cancer (CRC)
- +10 more
- Pembrolizumab
- +2 more
-
San Francisco, California
- +16 more
Mar 30, 2022
Relapsed DLBCL, Refractory DLBCL Trial in Tucson, Santa Monica, Lake Success (INCB053914, INCB050465)
Completed
- Relapsed Diffuse Large B-Cell Lymphoma
- Refractory Diffuse Large B-Cell Lymphoma
- INCB053914
- INCB050465
-
Tucson, Arizona
- +2 more
Nov 9, 2020